236 related articles for article (PubMed ID: 14744805)
1. Role of cyclic GMP on inhibition by nitric oxide donors of human eosinophil chemotaxis in vitro.
Thomazzi SM; Moreira J; Marcondes S; De Nucci G; Antunes E
Br J Pharmacol; 2004 Feb; 141(4):653-60. PubMed ID: 14744805
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects on human eosinophil chemotaxis in vitro by BAY 41-2272, an activator of nitric oxide-independent site of soluble guanylate cyclase.
Thomazzi SM; Moreira J; De Nucci G; Antunes E
Biochem Pharmacol; 2005 Mar; 69(6):875-82. PubMed ID: 15748699
[TBL] [Abstract][Full Text] [Related]
3. Expression of nitric oxide synthases and in vitro migration of eosinophils from allergic rhinitis subjects.
Ferreira HH; Lodo ML; Martins AR; Kandratavicius L; Salaroli AF; Conran N; Antunes E; De Nucci G
Eur J Pharmacol; 2002 May; 442(1-2):155-62. PubMed ID: 12020693
[TBL] [Abstract][Full Text] [Related]
4. Cyclic GMP mediates SIN-1-induced inhibition of human polymorphonuclear leukocytes.
Schröder H; Ney P; Woditsch I; Schrör K
Eur J Pharmacol; 1990 Jul; 182(2):211-8. PubMed ID: 1697805
[TBL] [Abstract][Full Text] [Related]
5. Investigation of the role of nitric oxide and cyclic GMP in both the activation and inhibition of human neutrophils.
Wanikiat P; Woodward DF; Armstrong RA
Br J Pharmacol; 1997 Nov; 122(6):1135-45. PubMed ID: 9401778
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide induces dose-dependent CA(2+) transients and causes temporal morphological hyperpolarization in human neutrophils.
Loitto VM; Nilsson H; Sundqvist T; Magnusson KE
J Cell Physiol; 2000 Mar; 182(3):402-13. PubMed ID: 10653607
[TBL] [Abstract][Full Text] [Related]
7. Evidence that different mechanisms underlie smooth muscle relaxation to nitric oxide and nitric oxide donors in the rabbit isolated carotid artery.
Plane F; Wiley KE; Jeremy JY; Cohen RA; Garland CJ
Br J Pharmacol; 1998 Apr; 123(7):1351-8. PubMed ID: 9579730
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide donors inhibit spontaneous depolarizations by L-type Ca2+ currents in alveolar epithelial cells.
Schobersberger W; Friedrich F; Hoffmann G; Völkl H; Dietl P
Am J Physiol; 1997 Jun; 272(6 Pt 1):L1092-7. PubMed ID: 9227509
[TBL] [Abstract][Full Text] [Related]
9. Positive and negative inotropic effects of NO donors in atrial and ventricular fibres of the frog heart.
Chesnais JM; Fischmeister R; Méry PF
J Physiol; 1999 Jul; 518 ( Pt 2)(Pt 2):449-61. PubMed ID: 10381591
[TBL] [Abstract][Full Text] [Related]
10. In vitro inhibition of human and rat platelets by NO donors, nitrosoglutathione, sodium nitroprusside and SIN-1, through activation of cGMP-independent pathways.
Priora R; Margaritis A; Frosali S; Coppo L; Summa D; Di Giuseppe D; Aldinucci C; Pessina G; Di Stefano A; Di Simplicio P
Pharmacol Res; 2011 Sep; 64(3):289-97. PubMed ID: 21539916
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological and immunohistochemical evidence for a functional nitric oxide synthase system in rat peritoneal eosinophils.
Zanardo RC; Costa E; Ferreira HH; Antunes E; Martins AR; Murad F; De Nucci G
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):14111-4. PubMed ID: 9391161
[TBL] [Abstract][Full Text] [Related]
12. Inhibition by nitric oxide-donors of human polymorphonuclear leucocyte functions.
Moilanen E; Vuorinen P; Kankaanranta H; Metsä-Ketelä T; Vapaatalo H
Br J Pharmacol; 1993 Jul; 109(3):852-8. PubMed ID: 8395300
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP.
Ebihara Y; Karmazyn M
Cardiovasc Res; 1996 Sep; 32(3):622-9. PubMed ID: 8881523
[TBL] [Abstract][Full Text] [Related]
14. The effect of nitric oxide-donating vasodilators on monocyte chemotaxis and intracellular cGMP concentrations in vitro.
Bath PM
Eur J Clin Pharmacol; 1993; 45(1):53-8. PubMed ID: 8405030
[TBL] [Abstract][Full Text] [Related]
15. The nitric oxide donors, SNAP and DEA/NO, exert a negative inotropic effect in rat cardiomyocytes which is independent of cyclic GMP elevation.
Sandirasegarane L; Diamond J
J Mol Cell Cardiol; 1999 Apr; 31(4):799-808. PubMed ID: 10329207
[TBL] [Abstract][Full Text] [Related]
16. Heme oxygenase-1 is a cGMP-inducible endothelial protein and mediates the cytoprotective action of nitric oxide.
Polte T; Abate A; Dennery PA; Schröder H
Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1209-15. PubMed ID: 10807735
[TBL] [Abstract][Full Text] [Related]
17. The role of cyclic guanylate monophosphate in nitric oxide-induced injury to rat small intestinal epithelial cells.
Tepperman BL; Abrahamson TD; Soper BD
J Pharmacol Exp Ther; 1998 Mar; 284(3):929-33. PubMed ID: 9495851
[TBL] [Abstract][Full Text] [Related]
18. The effect of nitric oxide donors on insulin secretion, cyclic GMP and cyclic AMP in rat islets of Langerhans and the insulin-secreting cell lines HIT-T15 and RINm5F.
Cunningham JM; Mabley JG; Delaney CA; Green IC
Mol Cell Endocrinol; 1994 Jun; 102(1-2):23-9. PubMed ID: 7926270
[TBL] [Abstract][Full Text] [Related]
19. Cyclic GMP-independent mechanisms contribute to the inhibition of platelet adhesion by nitric oxide donor: a role for alpha-actinin nitration.
Marcondes S; Cardoso MH; Morganti RP; Thomazzi SM; Lilla S; Murad F; De Nucci G; Antunes E
Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3434-9. PubMed ID: 16492779
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide donors suppress erythropoietin production in vitro.
Schobersberger W; Hoffmann G; Fandrey J
Pflugers Arch; 1996 Oct; 432(6):980-5. PubMed ID: 8781191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
